WebNov 23, 2024 · Frank Mccormick BBIO stock SEC Form 4 insiders trading. Frank has made over 2 trades of the BridgeBio Pharma Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently he sold 100,000 units of BBIO stock worth $4,276,000 on 13 November 2024.. The largest trade he's ever made was selling 100,000 units of … WebDec 22, 2024 · “Collaborative relationships between academia--which has a wealth of scientific knowledge in a range of overlooked diseases--and industry, with its robust …
BridgeBioR&D Day - Splash
WebFrank was Director at Olema, and Chief Scientific Officer at Onyx Pharmaceuticals. Frank McCormick is currently . Chairman of Oncology at BridgeBio - View - BridgeBio org chart; Director at PellePharm - View - PellePharm org chart; Set up your alert to follow the career of Frank McCormick. WebFeb 23, 2024 · In total, Frank McCormick has made about 5 transactions over 4 years of their time at Bridgebio Pharma, Inc. Frank McCormick usually trades in December, November, May, February and July, with the ... of tag\\u0027s
BridgeBio: Associate/Senior Associate, Asset Acquisition
WebApr 8, 2024 · BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) CEO Neil Kumar sold 120,000 shares of the company’s stock in a transaction that occurred on Wednesday, April 5th. The shares were sold at an average price of $15.46, for a total value of $1,855,200.00. Following the completion of the sale, the chief executive officer now owns 1,132,722 […] WebFrank McCormick, Ph.D., F.R.S., D.Sc. (Hon) has served as our Chairman of Oncology since April 2024. Dr. McCormick has held the positions of Director the UCSF Helen Diller Family Comprehensive Cancer Center, a multidisciplinary research and medical care organization and served as Associate Dean of the UCSF School of Medicine from 1997 … WebFeb 23, 2024 · Board of Directors: Appointed Frank McCormick, Ph.D., FS, DSc (Hon) to the BridgeBio Board of Directors. Dr. McCormick is a co-founder of BridgeBio and … myfreeview channel